Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name PRT062607
Trade Name
Synonyms P505-15|BIIB057
Drug Descriptions

PRT062607 is a selective inhibitor of SYK, which may lead to decreased tumor cell growth and increased sensitivity to chemotherapeutics (PMID: 23220742, PMID: 27406873).

DrugClasses SYK Inhibitor 15
CAS Registry Number 1370261-96-3


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
A-770041 + PRT062607 A-770041 PRT062607 0 0
Crenolanib + PRT062607 Crenolanib PRT062607 1 0
Dasatinib + PRT062607 Dasatinib PRT062607 0 0
Gilteritinib + PRT062607 Gilteritinib PRT062607 1 0
Midostaurin + PRT062607 Midostaurin PRT062607 3 0
PRT062607 PRT062607 0 0
PRT062607 + Quizartinib PRT062607 Quizartinib 2 0
PRT062607 + Sorafenib PRT062607 Sorafenib 2 0

Additional content available in CKB BOOST